---
layout: post
title: "Statement of Organization, Functions, and Delegations of Authority"
date: 2026-02-05 18:35:46 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-04009
original_published: 2023-03-02 00:00:00 +0000
significance: 8.00
---

# Statement of Organization, Functions, and Delegations of Authority

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** March 02, 2023 00:00 UTC
**Document Number:** 2023-04009

## Summary

The Secretary of Health and Human Services delegates to the Food and Drug Administration (FDA) Commissioner the authorities vested in the Secretary of Health and Human Services (the Secretary) under section 3855 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, as amended, to send annual letters to Congress regarding the progress of FDA in: evaluating the Over-the-Counter Monograph M012: Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use with respect to children under the age of 6, and as appropriate, revising that monograph through the order process of section 505G(b) of the Federal Food, Drug, and Cosmetic Act to address such children. These authorities may be redelegated. Exercise of this authority shall be in accordance with established policies, procedures, guidelines, and regulations as prescribed by the Secretary.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/02/2023-04009/statement-of-organization-functions-and-delegations-of-authority)
- API: https://www.federalregister.gov/api/v1/documents/2023-04009

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
